Federated Hermes’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-85
Closed -$1.14K 2189
2023
Q4
$1.14K Sell
85
-3
-3% -$40 ﹤0.01% 1970
2023
Q3
$1.09K Sell
88
-2
-2% -$25 ﹤0.01% 2005
2023
Q2
$1.11K Hold
90
﹤0.01% 2024
2023
Q1
$1.11K Hold
90
﹤0.01% 2041
2022
Q4
$1.03K Sell
90
-1
-1% -$11 ﹤0.01% 2052
2022
Q3
$1K Hold
91
﹤0.01% 2130
2022
Q2
$1K Hold
91
﹤0.01% 2125
2022
Q1
$1K Hold
91
﹤0.01% 2165
2021
Q4
$1K Sell
91
-129
-59% -$1.42K ﹤0.01% 2192
2021
Q3
$1K Hold
220
﹤0.01% 2195
2021
Q2
$1K Sell
220
-2
-0.9% -$9 ﹤0.01% 2185
2021
Q1
$1K Hold
222
﹤0.01% 2205
2020
Q4
$2K Sell
222
-111
-33% -$1K ﹤0.01% 2149
2020
Q3
$1K Sell
333
-59
-15% -$177 ﹤0.01% 2236
2020
Q2
$1K Sell
392
-635
-62% -$1.62K ﹤0.01% 2220
2020
Q1
$2K Sell
1,027
-805
-44% -$1.57K ﹤0.01% 2058
2019
Q4
$6K Hold
1,832
﹤0.01% 1952
2019
Q3
$8K Sell
1,832
-1,545
-46% -$6.75K ﹤0.01% 1913
2019
Q2
$16K Sell
3,377
-7,443
-69% -$35.3K ﹤0.01% 1840
2019
Q1
$59K Sell
10,820
-50,599
-82% -$276K ﹤0.01% 1639
2018
Q4
$187K Sell
61,419
-488
-0.8% -$1.49K ﹤0.01% 1563
2018
Q3
$260K Sell
61,907
-51,898
-46% -$218K ﹤0.01% 1570
2018
Q2
$440K Sell
113,805
-24,962
-18% -$96.5K ﹤0.01% 1431
2018
Q1
$879K Sell
138,767
-10,842
-7% -$68.7K ﹤0.01% 1267
2017
Q4
$1.21M Buy
+149,609
New +$1.21M ﹤0.01% 1152
2016
Q4
Sell
-12,710
Closed -$635K 2228
2016
Q3
$635K Buy
12,710
+2,542
+25% +$127K ﹤0.01% 1217
2016
Q2
$431K Hold
10,168
﹤0.01% 1317
2016
Q1
$670K Sell
10,168
-835
-8% -$55K ﹤0.01% 1198
2015
Q4
$684K Buy
11,003
+3,377
+44% +$210K ﹤0.01% 1201
2015
Q3
$511K Sell
7,626
-11,740
-61% -$787K ﹤0.01% 1276
2015
Q2
$1.88M Buy
19,366
+11,308
+140% +$1.1M 0.01% 941
2015
Q1
$753K Buy
8,058
+2,974
+58% +$278K ﹤0.01% 1260
2014
Q4
$452K Sell
5,084
-5,084
-50% -$452K ﹤0.01% 1373
2014
Q3
$702K Hold
10,168
﹤0.01% 1274
2014
Q2
$583K Buy
+10,168
New +$583K ﹤0.01% 1317